- The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry2022 | First Faculty of Medicine
- The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis2022 | First Faculty of Medicine
- Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration2021 | First Faculty of Medicine
- Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice2019 | First Faculty of Medicine
- Clinical farmakoiogie antirheumatic drugs2015 | Publication without faculty affiliation
- Juvenile idiopatic arthritis associated uveitis2018 | First Faculty of Medicine
- Denosumab in a rheumatologist's clinic2023 | First Faculty of Medicine
- What we can do for a patient with psoriatic arthritis when TNF inhibitors fail2019 | First Faculty of Medicine
- New view on interleukin-6 receptor blodkade in rheumatoid arthritis2018 | First Faculty of Medicine
- Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study2020 | Publication without faculty affiliation
- Rapid effect of TNF blocking therapy in psoriatic dactylitis2017 | Faculty of Medicine in Hradec Králové
- Biosimilar drugs: what a rheumatologist should know2023 | First Faculty of Medicine
- Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access2017 | First Faculty of Medicine